http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1322754-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51b4ec452333ce99ec253009f2281859 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451 |
| filingDate | 1987-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bbc21a1186d5641dbef180e54bba0d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f58e2f5a779f2d6e7284f1a90a5ea0cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaeb29febdeef68099a35ecc7952959c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea6be26d126859f25a811a608d592ba2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01fdb412a5da850c38d6487e0738be89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7817b3c8b53ae61285ff25aa7587cf5c |
| publicationDate | 1993-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1322754-C |
| titleOfInvention | Aralkyl-1,4-dihydropyridines, a method for their preparation and pharmaceutical compositions containing them |
| abstract | Abstract NEW ARALKYL-1,4-DIHYDROPYRIDINES, A METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 1,4-Dihydropyridines of formula I: (I) wherein: -X is a -CO2R1, cyano, nitro, -COCH3 group; -R and R1, that can be the same or different, are a primary, secondary or tertiary alkyl group, having from 1 to 6 carbon atoms, that can be saturated or unsaturated, linear or branched, and substituted or not by one or more hydroxy, monoalkylamino, dialkylamino, C1-C6-alkoxy, phenoxy or eventually substituted aryl; -R2 is hydrogen; -R3 is hydrogen or a hydroxy, -OCOR5, OSO2R6, azide, amino, -NHPO(OR7)2, -NHCOR5 group, a C1-C4-alkoxy group, halogen atom selected in the group of fluorine, chlorine, bromine or iodine, a SH group, a SCOR6 or a C1-C6 alkylthio, phenylthio or benzylthio group; R4 is an aromatic or heteroaromatic, non-substituted or mono- or polysubstituted group; - Y is one or more substituents, that can be the same or different, selected in the group formed by C1-C4-alkoxy, halogen, nitro, cyano, C1-C6-alkoxycar-bonyl, C1-C6-alkylthio, halo-C1-C6-alkyl, halo-C1-C6-alkoxy; - R5 is hydrogen or a C1-C4-alkyl, trihalomethyl, C1-C4-alkoxy or an unsubstituted or substituted phenyl group; - R6 is a C1-C4-alkyl, trihalomethyl, phenyl or p-methylphenyl group; - R7 is a C1-C4-alkyl group or a phenyl group; are useful as antihypertensive, cytoprotecting and anti-ulcer agents. |
| priorityDate | 1986-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 188.